Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginsenoside H dripping pills in advanced NSCLC
NCT02714608Phase 2Unknown
- Sponsor
- Tasly Group
- Start
- May 2016
- Primary completion
- May 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ginsenoside h in non-small cell lung cancer (NSCLC), sponsored by Tasly Group. Status: unknown.
02
Drugs
ginsenoside h
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02714608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714608.